At a "classical" neuronal synapse, neurotransmitter is released from presynaptic vesicles by exocytosis, crosses the synaptic cleft, and binds to receptors located postsynaptically. Implicit in this characterization is that neurotransmitter release sites at these synapses are closely apposed to the targeted receptor; neurotransmitter and receptor are separated only by the synaptic cleft and density between pre-and postsynaptic elements (1-4). Examples include glycinergic (3,4) and some glutamatergic synapses (1, 2) in the central nervous system (CNS) and cholinergic synapses in sympathetic ganglia (5) and at the adult neuromuscular junction (6).On the other hand, some -y-aminobutyric acid (GABA) receptors in the cerebellum are located at sites away from GABA-containing synapses, raising the possibility that GABA can act upon targets distant from its site of release, in a "nonsynaptic" fashion. The fact that postsynaptic densities are absent at some CNS monoaminergic synapses (7) suggests that norepinephrine and serotonin have a similar action. Peptide neurotransmitters, which often colocalize with more classical neurotransmitters (8), may also act in a diffuse, nonsynaptic manner. Thus, for example: (i) there are significant mismatches between the distribution of peptides and their respective binding sites (9-11); (ii) peptide neurotransmitters can diffuse away from their site of release (12, 13) and can even be recovered in spinal cord cerebrospinal fluid (14); (iii) binding sites for ju (15) and 8 (16) opioid peptides and for neurotensin (17) rarely overlap synaptic densities; (iv) dense core vesicles that contain neuropeptides are usually located away from the synaptic density, which is the presumed site of release of classical neurotransmitters (18,19); and (v) the locus of exocytosis of dense core vesicles can, in fact, be distant from the synaptic junction (density) (20,21). In the present report we use an antiserum directed against the substance P (SP) receptor (SPR), which corresponds to the NK-1 subtype of tachykinin receptors (22), and demonstrate that there is indeed significant mismatch at the synaptic level between peptide and peptide receptor. Furthermore, we demonstrate that the SPR decorates a large proportion of the somatic and dendritic surface of subpopulations of CNS neurons, indicating that much of the neuronal surface is a potential target of peptide neurotransmitter.
METHODSThe studies were performed on male Sprague-Dawley rats (240-260 g) that were deeply anesthetized with sodium pentobarbital (60 mg/kg) and perfused through the ascending aorta with 100 ml of 0.1 M sodium phosphate-buffered saline (PBS; pH 7.4) followed by a 0.1 M sodium phosphatebuffered fixative solution containing either 4.0%o paraformaldehyde (for light microscopy) or 2.0%o glutaraldehyde, 0.5% formaldehyde, and 0.2% picric acid (for both light and electron microscopy), according to the protocol of . After the perfusion the brain and spinal cord were removed and postfixed in the same solution for 2-4 hr.The au...